Connect with us

Health

Fight against cancer: GE Healthcare collaborates with Nigeria Sovereign Investment Authority

Published

on

GE Healthcare has partnered with the Nigeria Sovereign Investment Authority (NSIA) to supply latest technology in computed tomography (CT), Discovery RT, to Lagos University Teaching Hospital

LAGOS, Nigeria, February 28, 2019/ — Partnership will ensure provision of latest technology to enable early diagnostics and better treatment for cancer patients; NSIA- LUTH Cancer Center (NLCC) is the first hospital in West Central Africa to install GE Healthcare’s Discovery RT CT.

GE Healthcare (www.GEHealthcare.com) has partnered with the Nigeria Sovereign Investment Authority (NSIA) to supply latest technology in computed tomography (CT), Discovery RT, to Lagos University Teaching Hospital for its modern NSIA- LUTH Cancer Center, commissioned by President Muhammadu Buhari.

The Discovery RT, a simulation CT machine, is the first of such technology to be installed in the country. It enables physicians to study the body in detail allowing them to determine the exact location, shape, and size of the tumor to be treated. As part of the partnership, GE Healthcare will also provide servicing of the equipment and deliver hands-on training for the hospital’s radiology staff on the new technology.

Nigeria currently has eight public and one private comprehensive cancer care centers to serve its growing population of over 180 million people. Many of the public cancer centers have radiotherapy machines that are outdated, making access to radiation therapy more difficult for cancer patients. The new Radiotherapy Centre will increase access to quality services for the patients across Lagos state. This will help early detection and treatment of cancer, which improves chances of its being cured.

“For many years, GE Healthcare has developed tools that help improve the care of patients through advanced technologies that facilitate the diagnosis as well as help the fight against diseases such as cancer. We are happy to collaborate with NSIA in this landmark achievement for Nigeria in progressing the availability of world-class radiotherapy for cancer patients in the region. This will help improve the overall results in the fight against cancer, as well as in improving the quality of life”, said Eyong Ebai, General Manager for West Central and French Sub-Sahara Africa at GE Healthcare.

The World Health Organization (WHO) projects that by 2030, between 10 and 11 million cancers will be diagnosed in low and middle-income countries.

Health

Amref Health Africa Kenya Partners with Sisu Global Health and Surgipharm to improve access to blood

Published

on

By

Nairobi, Kenya, 17 September 2019 – Amref Health Africa in Kenya, Sisu Global Health and Surgipharm have today unveiled a partnership to improve access to blood and safer surgical outcomes during medical missions and emergencies in Kenya.

The partnership is aimed at increasing blood access in all hospitals to reduce internal bleeding-related deaths through the adoption of HemafuseTM, an innovative medical device that allows clinicians to reuse a patient’s own blood gathered from internal bleeding.

This initiative comes in the wake of the recent move by the US President’s Emergency Plan for AIDS Relief (PEPFAR) to stop its annual funding of KShs2 billion for blood collection and testing services in Kenya. This development comes at a time when the country is facing a chronic shortage of blood as the collection of blood has been plagued by the lack of funds for screening tools and human resources to collect and store blood.

“Blood access is critical to safe surgery. Standard surgical practices require two units of blood on-hand before surgery commences, but there is a severe shortage of blood in the country. Surgeries may be delayed or not performed due to a lack of blood, resulting in increased illness and death. This partnership will make use of an innovative solution that will ensure that patients with internal bleeding have a chance of survival,” said Amref Health Africa in Kenya’s Country Director, Dr Meshack Ndirangu.

HemafuseTM, a product by Sisu Global Health, can filter and pump blood from an internal haemorrhage into a blood bag, allowing it to be re-transfused to the same patient. The device can also be reused up to 25 times. This provides an alternative to donor blood.

“It is inspiring to see Hemafuse used to save lives. With this partnership with Kenya, we look forward to enabling thousands of more clinicians to save more lives across the country. The work we are doing is incredibly important and we are proud to have such a strong partnership with Amref to provide access to blood across Kenya,” said Sajju Jain, Chief Operating Officer at Sisu Global Health.

Also Read Prioritizing A Traditionally Underserved Somaliland Population Over Profit – Adan Abbey

Speaking at the event, Mr Rakesh Vinayak, Director-Sales & Marketing at Surgipharm, said that the pharmaceutical industry has a critical role to play in finding effective and sustainable solutions to providing access to today’s most pressing health concerns. “Surgipharm has a highly specialised and experienced management team and our relationships with different players in Kenya’s health sector complements and strengthens our existing skill set in logistics across the country. We are excited about the prospects that this partnership brings.”

Amref Health Africa

Continue Reading

Health

Memfys Hospital and GE Healthcare Collaborate to Improve Disease Diagnosis for Nigeria’s South-East Regions

Published

on

By

Memfys is the first hospital in South-East Nigeria to install GE Healthcare’s SIGNA™ Explorer 1.5Tesla MRI system

LAGOS, Nigeria, August 29, 2019 – The collaboration will help provide innovative technology to enable early diagnosis and detection of diseases; Memfys is the first hospital in South-East Nigeria to install GE Healthcare’s SIGNA™ Explorer 1.5Tesla MRI system.

GE Healthcare has partnered with Memfys Hospital to provide the SIGNA™ Explorer 1.5Tesla MRI system services and training to advance early diagnosis of diseases. By providing clinicians with detailed information about diseases such as cancer, neurological disorders and heart diseases, the new equipment will help the hospital to deliver high quality medical services and better care to more patients across the region.

As the only dedicated Neurosurgery hospital in South-East Nigeria, Memfys Hospital is serving a population of over 60 Million People. Investing in the latest technologies such as the SIGNA™ Explorer 1.5Tesla MRI system will help improve the hospital’s diagnostic capabilities for early detection of diseases and at the same time keep up with global best practices to provide the very best for the country and West Africa region at large.

“As a leader in the neurosurgical space, we are committed to continue providing high quality patient care using modern, high tech and reliable equipment that meets the recommendation by the World Federation of Neurosurgical Societies (WFNS). Acquisition of the SIGNA™ Explorer is a huge milestone towards this commitment,” said Professor Samuel C. Ohaegbulam, CEO Global Memfys & Co Ltd.

To ensure sustainability of such investments, Memfys hospital is providing training for both young and experienced doctors embarking on a career in Neurosurgery and Spinal surgery. The hospital is accredited by the West African College of Surgeons (WACS) for full training in neurosurgery making it the only private health institution to enjoy this status in all of Africa. To date, Memfys has trained 20 neurosurgeons and about 10 senior residents.

“We are committed to continue collaborating with both private and public partners to co-create solutions that help tackle pressing healthcare challenges for our region such as Noncommunicable diseases (NCDs), as we strive towards Universal Health Coverage. With the SIGNA™ Explorer 1.5Tesla MRI system, the people of South-East Nigeria will not need to leave the region for such specialized services as it has been the practice in the past,” said Eyong Ebai, General Manager for West & Central and French Sub-Sahara Africa Region.

Also Read Lebohang Lebogo: First generation drone pilot delivering blood for SANBS

According to WHO’s 2018 report, NCDS including stroke, cardiovascular diseases, cancers, chronic respiratory diseases  and diabetes are estimated to account for 71% of the 57 million global deaths, while in Nigeria NCDs are estimated to account for 29% of all deaths (2.1M). Early diagnosis of diseases such as cancer improves outcomes by providing care at the earliest possible stage.

– GE.

Continue Reading

Health

Egypt denies postponing official launch of health insurance system

Published

on

By

Hala Zayed, Minister of Health Pic: Egypt Today

CAIRO – 29 August 2019: Egypt denied delaying the official launch of the comprehensive health insurance system in Port Said, which is scheduled for the first half of coming Septwmbwe, due to failure of teh pilot phase, according to the cabinet’s media center.

Ministry of Health confirmed that the effective implementation of the system will start in the first half of September, especially after the success of the pilot, the center added in a statement.

Earlier in August, President Abdel Fatah al-Sisi called for implementing the health insurance system, taking into consideration the technical, human and medical sides to ensure the good quality of medical services.

Also Read Lebohang Lebogo: First generation drone pilot delivering blood for SANBS

In July, the pilot operation of the comprehensive health insurance system in Port Said governorate started in July.

Prime Minister Mostafa Madbouly said earlier in a press conference that the governorate will be the first to benefit from the new system through 11 general and specialized hospitals and 32 healthcare units.

– Egypt Today 

Continue Reading

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,797 other subscribers

Ads

Most Viewed